Evidence map›Paper›PMID 25887546›Full record

Observational studyBMC geriatrics2015

Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors.

Antonio San-José, Antonia Agustí, Xavier Vidal, Francesc Formiga, Mercedes Gómez-Hernández, Juana García, Alfonso López-Soto, Nieves Ramírez-Duque, Olga H Torres, José Barbé and 1 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC geriatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Central nervous system medication use around hospitalization.Journal of the American Geriatrics Society · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Antonio San-JoséInternal Medicine Service, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Àrea General 3ª planta, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. asanjose@vhebron.net.
Antonia AgustíClinical Pharmacology Service, Fundació Institut Català de Farmacologia, Hospital Universitari Vall d'Hebron, Departament of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain. Antonia.ficf@gmail.com.
Xavier VidalClinical Pharmacology Service, Fundació Institut Català de Farmacologia, Hospital Universitari Vall d'Hebron, Departament of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain. xvg@icf.uab.cat.
Francesc FormigaInternal Medicine Service, Hospital Universitari de Bellvitge. Hospitalet de Llobregat, Barcelona, Spain. fformiga@bellvitgehospital.cat.
Mercedes Gómez-HernándezInternal Medicine Service, Hospital San Juan De Dios del Aljarafe, Sevilla, Spain. merxe84@msn.com.
Juana GarcíaInternal Medicine Service, Hospital General Juan Ramón Jiménez, Huelva, Spain. gamoju@gmail.com.
Alfonso López-SotoInternal Medicine Service, Hospital Clínic, Barcelona, Spain. alopez@clinic.ub.es.
Nieves Ramírez-DuqueInternal Medicine Service, Hospital Universitario Virgen del Rocío, Sevilla, Spain. nievesramirezduque@yahoo.es.
Olga H TorresInternal Medicine Service, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. otorres@santpau.cat.
José BarbéInternal Medicine Service, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Àrea General 3ª planta, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. jbarbe@vhebron.net.
Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScientific evidence on treatments of chronic diseases in patients 85 years old or older is very limited, as is available information on inappropriate prescription (IP) and its associated factors. The study aimed to describe medicine prescription, potentially inappropriate medicines (PIM) and potentially prescribing omissions (PPO) and their associated factors on this population.

methodsIn the context of an observational, prospective and multicentric study carried out in elderly patients admitted to seven Spanish hospitals for a year, a sub-analysis of those aged 85 years and over was performed. To assess PIMs, the Beers and STOPP criteria were used, and to assess PPOs, the START and the ACOVE-3 criteria were used. To assess factors associated with IP, a multivariate logistic regression analysis was performed. Patients were selected randomly every week on consecutive days from the hospitalization lists.

resultsA total of 336 patients were included in the sub-analysis with a median (Q1-Q3) age of 88 (86-90) years. The median medicines taken during the month prior to admission was 10 (7-13). Forty-seven point two per cent of patients had at least one Beers-listed PIM, 63.3% at least one STOPP-listed PIM, 53.6% at least one START-listed PPO, and 59.4% at least one ACOVE-3-listed PPO. Use of benzodiazepines in patients who are prone to falls (18.3%) and omission of calcium and vitamin D supplements in patients with osteoporosis (13.3%) were the most common PIM and PPO, respectively. The main factor associated with the Beers-listed and the STOPP-listed PIM was consumption of 10 or more medicines (OR = 5.7, 95% CI 1.8-17.9 and OR = 13.4, 95% CI 4.0-44.0, respectively). The main factors associated with the START-listed PPO was a non-community dwelling origin (OR 2.3, 95% CI 1.0-5.0), and multimorbidity (OR1.8, 95% CI 1.0-3.1).

conclusionsPrescribed medicines and PIM and PPO prevalence were high among patients 85 years and over. Benzodiazepine use in those who are prone to falls and omission of calcium and vitamin D in those with osteoporosis were the most frequent PIM and PPO, respectively. Factors associated with PIM and PPO differed with polypharmacy being the most important factor associated with PIM.

Indexed as

Chronic DiseaseInappropriate PrescribingPolypharmacyAgedAged, 80 and overBenzodiazepinesBone Density Conservation AgentsCalcium CompoundsDrug PrescriptionsFemaleHospitalsHumansMalePractice Patterns, Physicians'PrevalenceProspective StudiesBenzodiazepinesBone Density Conservation AgentsCalcium CompoundsVitamin D

Identifiers

PMID25887546
PMCPMC4403827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.